Mannose-binding lectin (MBL) is a recognition molecule of the lectin pathway of complement activation and its serum levels are largely determined by frequently occurring polymorphisms of the MBL gene. We questioned whether MBL deÀ ciency inÁ uences infectious complications after simultaneous pancreas-kidney transplantation (SPKT).
Introduction
Simultaneous pancreas-kidney transplantation (SPKT) offers the opportunity to correct both renal failure and the underlying metabolic disease in type 1 diabetics with severe diabetic nephropathy. Technical success rates have improved and SPKT has become a routine procedure in many transplant centers. Nevertheless, this procedure is still characterized by a high rate of rejection [1] and infectious complications [2] when compared to kidney transplantation alone.
The complement system plays an important role in solid organ transplantation in both ischemia/reperfusion injury and rejection-mediated damage [3;4] . Mannosebinding lectin (MBL) is a major initiation molecule of the lectin pathway of complement activation and its levels are largely determined by polymorphisms within exon 1 and the promoter region of the MBL-2 gene. MBL binds to carbohydrate moieties of pathogens and damaged host tissue which leads to opsonisation and activation of the complement cascade. We recently reported a strong association of high MBL levels with mortality and graft loss in SPKT recipients [5] , a À nding possibly explained by a contribution of the lectin pathway to tissue damage occurring during ischemia/ reperfusion injury. Experimental data have demonstrated an important role of the lectin pathway in ischemia/reperfusion damage of the heart and kidney [6;7] . On the other hand, the lectin pathway may be of particular importance in host defense in the immune compromised host. Various studies have linked low serum levels of MBL and MBL SNPs to increased infectious complications in various settings of impaired immunity including cystic À brosis and early childhood [8;9] . Medical interventions associated with states of impaired adaptive immunity such as stem cell transplantation and chemotherapy have also been associated with increased infection rates in the presence of low MBL levels [10;11] . We recently showed that the transplantation of livers with variant MBL genotypes results in low MBL levels in the recipient and an signiÀ cantly increased rate of severe infections [12] .
Taken together, MBL deÀ ciency can have dual effects, dependent on the clinical situation. In our recent publication on the role of MBL in SPKT [5] , we showed that a low-MBL status is clinically beneÀ cial, since it is associated with lower mortality and less graft loss. In line with the well-established role of MBL in host defense, we now report that a low-MBL status of the recipient is strongly associated with an increased susceptibility to infections in this highly infection-prone cohort of immunosuppressed patients. In particular, results indicate an association of low MBL levels with an increased risk for urinary tract infections after SPKT.
Materials and Methods
From January 1990 until July 2005, 183 simultaneous pancreas/kidney transplantations were performed in the Leiden University Medical Center. Ten recipients were excluded because they lost their pancreas allograft within one week after transplantation due to arterial thrombosis. A pre-transplant serum sample was available from 152 of the 173 remaining patients. In 144 of these patients exocrine pancreatic juices were drained via the bladder and primary enteric drainage was used in 8 patients.
Data analysis was performed using the Leiden Transplant Database containing donor variables (gender, date of birth and death, cytomegalovirus (CMV) status, transplantation date), recipient variables (gender, age at time of transplantation, CMV status) and post-transplantation features (immune suppression, rejection history, rejection treatment and graft loss). This information was collected routinely for all transplant patients. After transplantation, patients were followed until death or July
2006.
The study was performed according to the guidelines of the ethics committee of the Leiden University Medical Center and patient anonymity was maintained.
Antibiotic prophylaxis
As viral prophylaxis high dose acyclovir (57 patients), valaciclovir (12 patients) or ganciclovir (44 patients) was given during the À rst year after transplantation. 
Infections
All clinically signiÀ cant infections (site, pathogen, antibiotic treatment) were scored retrospectively with a follow-up of one year after transplantation using Center for Disease Control and Prevention (CDC) criteria [13] . Infection was deÀ ned as a positive culture from the site expected to be the focus of infection followed by subsequent appropriate antibiotic therapy.
Criteria for the most frequent infections are brieÁ y described. Urinary tract infections (UTI) were divided into cystitis, pyelonephritis and urosepsis. Cystitis was deÀ ned as a positive urine culture (> 10 4 cfu/ml) and pyuria with or without other symptoms. Pyelonephritis was deÀ ned as a positive urine culture, pyuria and fever (>38.5°C). If blood culture was also positive, the infection was scored as urosepsis.
Wound infections (surgical site infections) were divided in superÀ cial and deep 
ELISA
Serum MBL concentrations were assessed by sandwich ELISA as described previously [14] . In short, 96-well ELISA plates were coated with 3E7 (mouse IgG1 anti-MBL at 5 õg/mL). After blocking residual binding sites with PBS containing 1% BSA, serum samples were diluted 1:50 and 1:500 in PBT (PBS containing 1% BSA and 0.05% Tween 20) and incubated. Dig-conjugated 3E7 was added as second antibody. Detection of MBL binding was performed by adding Fab anti-Dig-HRP (Fab fragments, Roche, Mannheim, Germany) followed by enzyme activity detection with ABTS (Sigma Chemical Co., St. Louis, MO). Optical density was measured at 415 nm using a micro plate biokinetics reader (EL312e, Biotek Instruments, Winooski, VT). A calibration line was obtained using a serial dilution of human serum with a known concentration of MBL. 
Statistical analysis
Logistic regression analysis was used to test the inÁ uence of MBL on the different infectious parameters. MBL concentrations < 400 ng/mL were classiÀ ed as low MBL, whereas MBL > 400 ng/mL were considered normal/high MBL levels. Categorical characteristics among the different MBL groups were compared using cross tables with calculations of exact p-values using the Pearson Chi-Square test or with the Fisher's Exact test. Continuous variables were analyzed using the Student's t-test, when test assumptions were met, and otherwise with the Mann-Whitney test. To identify independent risk factors for infectious complications multivariate binary logistic regression analysis was performed. The forced entry method was applied.
P-values of < 0.05 were considered to be statistically signiÀ cant. All analyses were performed with SPSS Statistical Software Package (version 12.01, SPSS Inc.).
Results
Patient characteristics of the 152 selected patients are summarized in table 1. Their mean age was 40.8 years and 62% were male. One year patient survival was 95.3% and death censored pancreas and kidney allograft survival were 92.8% and 96.1%, respectively.
Infectious complications after SPKT
We recorded 529 clinically relevant infections during the À rst year after transplantation and 138 SPKT recipients (90.8%) experienced at least one infection. The majority, 118 patients (78%) were treated for cystitis, 34 (22%) had at least one episode of pyelonephritis and 20 episodes of urosepsis were recorded in 19 patients (13%).
Wound infections were registered in 48 patients (32%) and 46 patients were treated for CMV infection (30%). The distribution of infectious episodes during the À rst year after SPKT is shown in table 2. Women experienced signiÀ cantly more urinary tract infections than men (4.4 vs 2.9 episodes per patient, P = 0.001). Escherichia coli was the most frequent cause of urinary tract infections (33%) followed by Enterococcus faecalis (20%) and coagulase negative staphylococci (15%). In 7 cases of bacteremia no deÀ nite focus could be identiÀ ed. Of the 8 patients with primary enteric drainage, 2 suffered from urinary tract infections, of which one developed urosepsis. Two patients developed CMV disease and 3 had a wound infection. Four of these 8 patients had no infections in the À rst year after transplantation. 
MBL and Infections
The median MBL level in the study population was 904 ng/ml (range 24-5153). We À rst examined the inÁ uence of MBL on infectious complications in steps of 500 ng/ ml (table 3) . For every 500 ng/mL increase in baseline MBL an odds ratio of 0.84 (P = 0.045) for urinary tract infections, of 0.68 (P= 0.029) for urosepsis and of 0.70 (P = 0.016) for all episodes of bacteremia was detected. With this analysis no signiÀ cant inÁ uence of increasing MBL levels could be detected for the development of cystitis, pyelonephritis, wound infection, or CMV disease. Figure 1 shows the pre-transplantation MBL concentrations of the patients without UTI (median 1634 ng/mL), with cystitis (median 810 ng/mL), and with urosepsis (median 373 ng/mL). Differences in median baseline MBL were signiÀ cant between groups (no UTI vs. cystitis, P = 0.013, no UTI vs. urosepsis, P = 0.001).
A cut-off of 400 ng/ml was used to differentiate between high and low MBL levels.
This cut-off level had been established in earlier studies and strongly correlates with the presence of MBL polymorphisms [15;16] . Furthermore, in a receiver operator characteristics analysis a cut-off level around 400 ng/ml was determined to have the best possible signiÀ cance and speciÀ city for predicting infectious complications.
Twenty-nine % of the SPKT cohort had MBL levels below this cut-off. Table 3 shows the characteristics and infectious complications in the high and low MBL recipients.
The sex and age distribution was similar in both groups. The high and low MBL groups had the same incidence of acute rejection (68.5% vs. 68.2%., P = 0.556). UTI (95.5%
vs. 80.6%, P = 0.023), cystitis (88.6% vs. 73.1%, P = 0.038) and urosepsis (22.7% vs.
8.3%, P = 0.015) were signiÀ cantly more common in patients with low baseline MBL compared to the high MBL group. Episodes of pyelonephritis were also more frequent in the low MBL group, but this difference did not reach statistical signiÀ cance (P = 0.074). The total number of UTI per patient was signiÀ cantly higher in the low MBL group (2.93 vs. 2.16, P = 0.036). Although infectious complications were more common in patients with low baseline MBL, MBL was not associated with increased infection-related mortality. Only 4 patients in the entire cohort died of infections during the À rst year after transplantation. (table 5a) . A baseline MBL level below 400 ng/mL was associated with an odds ratio of 3.58 for developing urosepsis (P = 0.016). Interestingly the introduction of cotrimoxazol prophylaxis did not reduce the risk of urosepsis in our cohort. When multivariate analysis was performed primary enteric drainage was associated with an odds ratio of 0.11 for cystitis (P = 0.014). Male recipients had an odds ratio of 0.4 (P = 0.059) for experiencing cystitis and baseline MBL levels below 400 ug/ml were associated with an odds ratio of 2.78 (P = 0.064) (table 5b). Cotrimoxazol prophylaxis did not have a beneÀ cial effect on the prevention of cystitis. SigniÀ cant p-values are bold and underlined. MBL, mannose-binding lectin
Discussion
Our previous study on the role of the lectin pathway in SPKT showed that low MBL levels were associated with superior organ and graft survival [5] . We wondered whether this survival advantage was associated with the disadvantage of more infectious complications. In the current study, we now show that low MBL levels indeed are associated with an increased risk of infections after SPKT. Transplant recipients with MBL levels below 400 ng/ml had a higher risk of bacterial cystitis and more episodes of urosepsis as compared to patients with MBL levels above 400 ng/ ml. In the multivariate analysis MBL deÀ ciency was the only identiÀ able risk factor for urosepsis.
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The innate immune system is of particular importance in patients with a suppressed adaptive immune system. MBL binds to a broad range of microorganisms one clinical signiÀ cant infection in their À rst year after transplantation, in spite of the given antibiotic prophylaxis. Especially UTI are a major problem, since 85% of the patients experienced at least one episode and 59% experienced recurrent UTI. This high rate of UTI is probably related to pre-existing bladder dysfunction, the use of catheters and in particular the metabolic and anatomic consequences of the exocrine drainage of the pancreas to the bladder next to the intense immunosuppression.
Although only 8 patients in our cohort had primary enteric drainage of the pancreas, a signiÀ cant protective effect against cystitis was detected when compared with primary bladder drainage.
Interestingly, low MBL levels were not only associated with urosepsis but also with an increased occurrence of uncomplicated cystitis. We are not aware of any studies examining the role of MBL in cystitis. At this point we do not know whether MBL enters the urinary tract via the kidney or whether it is possibly produced by urothelial cells. In a preliminary study we were able to detect low levels of MBL in urine during urinary tract infections in transplant recipients (unpublished observations).
Different cut-off values for serum MBL levels have been used in several studies to deÀ ne MBL-deÀ ciency. However it is likely that the physiologically relevant MBL level resulting in clinical manifestations differs in different diseases. Genotyping has also been used. The drawback of this classiÀ cation is that individuals with identical genotypes for all known variants may differ up to 10-fold in MBL levels [20] . From analysis with different cut-off levels of MBL, it appeared that 400 ng/ Chapter 5 78 mL was the most optimal cut-off level in our patient group of SPKT patients. This cut-off was found earlier to clearly distinguish between wildtype MBL individuals and those with a polymorphism [16] . On the other hand we did also À nd a continuous effect when MBL was studied in steps of 500 ng/ml. This indicates that higher MBL levels are associated with increasing antibacterial protection, most likely also in a range of MBL concentrations that are subject to regulation of expression by promoter polymorphisms, rather than associated with genetically-based deÀ ciency.
A recent study demonstrated that MBL levels determined under baseline conditions are highly predictive of MBL levels during the acute phase response after surgery [21] , justifying the use of pre-transplant sera in our study. Due to lack of international standardization it must be noted that the used cut-off level of 400 ng/ml refers to our well established in house ELISA [16] and the cut-off levels may be somewhat different in other test systems using other MBL-detecting antibodies.
Our study demonstrates increased susceptibility to urinary tract infections after SPKT in patients with low MBL levels (<400 ng/mL) compared to patients with high MBL levels. A recently published study investigated MBL polymorphisms in non-transplanted females with pyelonephritis due to Escherichia coli [22] . MBL polymorphisms associated with low levels of MBL were not more frequent in women with pyelonephritis when compared with a control population and were not associated with an increased risk of bacteremia. The discrepancies between our study and these 
Conclusion
Although MBL deÀ ciency is favorable for patient and graft survival following SPKT, we now show that MBL deÀ ciency is associated with urinary tract infections and more speciÀ cally with an increased incidence of urosepsis after SPKT. These data indicate an important role of the innate immune system in antimicrobial defense in immune compromised transplant recipients. If conÀ rmed, pre-transplant MBL levels may support risk stratiÀ cation prior to SPKT and guide decisions concerning the method of exocrine pancreatic drainage and antimicrobial prophylaxis.
